Carrizzo, Albino
Iside, Concetta
Nebbioso, Angela
Carafa, Vincenzo
Damato, Antonio
Sciarretta, Sebastiano
Frati, Giacomo
Di Nonno, Flavio
Valenti, Valentina
Ciccarelli, Michele
Venturini, Eleonora
Scioli, Mariarosaria
Di Pietro, Paola
Bucci, Tommaso
Giudice, Valentina
Storto, Marianna
Serio, Bianca
Puca, Annibale Alessandro
Giugliano, Giuseppe
Trimarco, Valentina
Izzo, Raffaele
Trimarco, Bruno
Selleri, Carmine
Altucci, Lucia
Vecchione, Carmine http://orcid.org/0000-0002-2473-4565
Funding for this research was provided by:
Ministero della Salute (GR-2018- 12366268)
Università degli Studi di Salerno
Article History
Received: 25 February 2022
Revised: 1 June 2022
Accepted: 13 June 2022
First Online: 11 July 2022
Declarations
:
: C.V., L.A, A.N., A.C., and C.I. are holders of WO 2020/245468 A1 patent application relating to ISIDE: IDENTIFICATION AND CHARACTERIZATION OF A NOVEL SIRT1 ACTIVATOR AGAINST CARDIOVASCULAR DISEASES, sponsored by Epi-C srl. The other authors declare that they have no competing interests.
: All animal experiments were approved by the Institutional Animal Care and Use Committee. All human experiments were performed in accordance with the Declaration of Helsinki and after approval of the Ethical Committee of Istituto Neurologico Mediterraneo IRCCS Neuromed.
: All the authors consent to publication and approve of this version of the paper.